1.
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
by Simpson, C R
Nature medicine, 2021-07, Vol.27 (7), p.1290-1297
2.
CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial
by Anon
The Lancet (British edition), 2015, Vol.385 (9985), p.2383-2391
3.
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
by Barnett, Karen, PhD
The Lancet (British edition), 2012, Vol.380 (9836), p.37-43
4.
Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
by Patone, Martina
Nature medicine, 2021-12, Vol.27 (12), p.2144-2153
5.
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
by Levin, D
Diabetologia, 2015, Vol.58 (3), p.493-504
6.
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study
by Kavanagh, Kimberley
The Lancet infectious diseases, 2017-12, Vol.17 (12), p.1293-1302
7.
Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
by Carstensen, Bendix
Diabetologia, 2016-02-29, Vol.59 (5), p.980-988
8.
Scottish outcomes for extra hepatic biliary atresia post-rationalisation of services
by Tayler, Rachel
Archives of disease in childhood, 2013-05, Vol.98 (5), p.381-383
9.
Metabolically Healthy Obesity and Risk of All-Cause and Cardiovascular Disease Mortality
by Hamer, Mark
The journal of clinical endocrinology and metabolism, 2012-07, Vol.97 (7), p.2482-2488
10.
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
by Shields, B. M
Diabetologia, 2010-05-25, Vol.53 (12), p.2504-2508
11.
Prevalence of frailty and its association with mortality in general surgery
by Hewitt, Jonathan, M.B.B.S., Ph.D
The American journal of surgery, 2015, Vol.209 (2), p.254-259
12.
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
by Colhoun, H. M
Diabetologia, 2009-07-15, Vol.52 (9), p.1755-1765
13.
The Thyroid Epidemiology, Audit, and Research Study (TEARS): Morbidity in Patients with Endogenous Subclinical Hyperthyroidism
by Vadiveloo, Thenmalar
The journal of clinical endocrinology and metabolism, 2011-05, Vol.96 (5), p.1344-1351
14.
Diabetes and pregnancy: national trends over a 15 year period
by Mackin, Sharon T
Diabetologia, 2018-01-11, Vol.61 (5), p.1081-1088
15.
Adverse events after first, single, mesh and non-mesh surgical procedures for stress urinary incontinence and pelvic organ prolapse in Scotland, 1997–2016: a population-based cohor...
by Morling, Joanne R, PhD
The Lancet (British edition), 2016, Vol.389 (10069), p.629-640
16.
Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection—Scotland, 2012–2013
by Rajendran, R
Clinical microbiology and infection, 2016-01, Vol.22 (1), p.87-93
17.
Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013
by Read, Stephanie H
Diabetologia, 2016-07-28, Vol.59 (10), p.2106-2113
18.
Consequences of being overweight or obese during pregnancy on diabetes in the offspring: a record linkage study in Aberdeen, Scotland
by Lahti-Pulkkinen, Marius
Diabetologia, 2019-06-19, Vol.62 (8), p.1412-1419
19.
Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections ac...
by Lawes, Timothy, MSc
The Lancet infectious diseases, 2015, Vol.15 (12), p.1438-1449
20.
Prevalence of overweight and obesity among nurses in Scotland: A cross-sectional study using the Scottish Health Survey
by Kyle, Richard G
International journal of nursing studies, 2016-01, Vol.53, p.126-133
